Acadia Pharmaceuticals reported $-42000000 in Pre-Tax Profit for its second fiscal quarter of 2020.

Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
Pre Tax Profit Change
Acadia Pharmaceuticals ACAD:US $ -42M 47M
Adamas Pharmaceuticals ADMS:US $ -11M 6M
Alexion Pharmaceuticals ALXN:US $ 827.7M 41M
Alnylam Pharmaceuticals ALNY:US $ -252.45M 74.23M
Biomarin Pharmaceutical BMRN:US $ -15.97M 117.32M
Bristol Myers Squibb BMY:US $ 4357M 361M
Cytokinetics CYTK:US $ -3.18M 37.6M
Eisai 4523:JP Y 32448M 19806M
Eli Lilly And LLY:US $ 1988.3M 137.6M
Gw Pharmaceuticals GWPH:US $ -14.58M 6.88M
Intercept Pharmaceuticals ICPT:US $ -63.28M 29.7M
Johnson & Johnson JNJ:US $ 7246M 1909M
Neurocrine Biosciences NBIX:US $ 83M 45M
Pfizer PFE:US $ 5152M 170M
Prothena PRTA:US $ -30.79M 4.26M
Ptc Therapeutics PTCT:US $ -170.73M 58.26M
Sarepta Therapeutics SRPT:US $ -151M 133M
Seattle Genetics SGEN:US $ 639.41M 660.6M
Ultragenyx Pharmaceutical RARE:US $ 25.73M 152.43M
Vanda Pharmaceuticals VNDA:US $ 11.09M 9.85M
Vertex Pharmaceuticals VRTX:US $ 870.63M 11.79M
YTE INCY:US $ 292.96M 894.15M
Zogenix ZGNX:US $ -26M 31M